Active not recruitingOBSERVATIONAL

Follow-up in Gynecological Cancer Survivors

This research is looking into the experiences of women who have finished their main treatment for gynaecological cancer, such as cervical, ovarian, or womb cancer. The study wants to find out what physical and emotional issues, as well as specific needs, these women might have after their treatment. Around 1100 patients will be asked to complete a detailed questionnaire about their quality of life. By collecting information about their cancer type, treatment history, and personal details, the researchers hope to identify common problems and understand what factors might lead to a reduced quality of life or sexual health. The aim is to help improve support for gynaecological cancer survivors in the future.

At a glance

Status

Active not recruiting

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Enrolment target

1,100

Start

21 Feb 2019

Estimated completion

31 Aug 2026

Gynecologic Cancer

What is this study about?

This research project, called "Follow-up in Gynaecological Cancer Survivors," is all about understanding life after treatment for gynaecological cancers. After someone is treated for cancer, life doesn't always go straight back to normal. Many women experience ongoing physical or emotional challenges, and sometimes their needs aren't fully met.

The main goal of this study is to identify what these physical, emotional, and social challenges are. By gathering information directly from patients, the researchers hope to get a clear picture of what women go through. They also want to identify patterns, meaning they want to see if certain types of cancer, particular treatments, or even aspects of a woman's personal life are linked to specific problems or a lower quality of life.

Ultimately, the findings from this study could be really important. By understanding these issues better, healthcare providers and support organisations can work towards improving the care and support available for women who have successfully completed their treatment for gynaecological cancer.

Key takeaways

A UK study for women treated for gynaecological cancer.
Aims to understand physical and emotional challenges after treatment.
Involves completing a 'Quality of Life' questionnaire once.
No new treatments or clinic visits required.
Helps improve future support for cancer survivors.
For those 18+ and disease-free for at least 6 months post-treatment.

Who may be eligible?

To be considered for this study, you would need to be a woman aged 18 or over who has been diagnosed with a gynaecological cancer (like cervical, womb, ovarian, or vulval cancer) that has been confirmed through laboratory tests. You must also have finished your main cancer treatment at least 6 months ago, but no more than 5 years ago, and currently show no signs that your cancer has returned.

Your general health should be good enough to comfortably take part in the study, and you must be able to understand and complete questionnaires. It's important that you haven't been diagnosed with any other cancer in the last five years, and you shouldn't be involved in another study that is primarily focused on quality of life. Also, any significant medical or personal circumstances that might make it difficult for you to follow the study's plan would mean you couldn't take part.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you female and aged 18 or over?
Have you been treated for a gynaecological cancer (cervical, womb, ovarian, vulval)?
Did you complete your main cancer treatment between 6 months and 5 years ago?
Are you currently free from any signs of your cancer returning?
Do you feel well enough to complete a questionnaire?
Have you *not* had another cancer diagnosis in the last 5 years?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, the process is straightforward. You will be asked to fill out a detailed questionnaire that includes 76 questions about your quality of life. This will only happen once, at a single point in time. The research team will also collect some information about your medical history, including details about your cancer type and treatments, from your existing records. There are no clinic visits, medications, or ongoing follow-up appointments specifically for this study. Your participation simply involves completing the questionnaire and allowing your medical information to be reviewed for research purposes. The total duration of your active involvement in the study will be the time it takes you to complete the questionnaire.

Potential risks and benefits

A potential benefit of taking part is contributing to a better understanding of the challenges women face after gynaecological cancer treatment, which could lead to improved support for future patients. There are no direct medical benefits to you personally from this study. The main risk is the time and emotional effort involved in answering detailed questions about your health and quality of life, which some might find upsetting. You are free to withdraw from the study at any time without giving a reason, and this would not affect your medical care.

Locations (21)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Medical University of Graz
Verified postcode
Graz, Austria
ZNA Middelheim
Verified postcode
Antwerp, Belgium
Universitair Ziekenhuis Gent
Verified postcode
Ghent, Belgium
Centre Hospitalier Chretien (CHC) - CHC MontLegia
Verified postcode
Liège, Belgium
ZNA Jan Palfijn
Verified postcode
Merksem, Belgium
Universitaetsklinikum Schleswig-Holstein - Campus Kiel
Verified postcode
Kiel, Germany
HELIOS Kliniken - Helios Klinikum Wuppertal - Klin. Univ. Witten / Herdecke
Verified postcode
Wuppertal, Germany
Ospedale San Gerardo
Verified postcode
Monza, Italy
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Verified postcode
Naples, Italy
Azienda Ospedaliera Ordine Mauriziano di Torino
Verified postcode
Torino, Italy
King Hussein Cancer Center
Verified postcode
Amman, Jordan
Radboudumc - Radboud University Medical Center Nijmegen
Verified postcode
Nijmegen, Netherlands

Common questions

What types of cancer are included?

This study includes cervical, womb (endometrial), ovarian (including fallopian tube and peritoneal), and vulval cancers.

How long has to have passed since treatment?

You need to have finished your main cancer treatment at least 6 months ago, but no more than 5 years ago, to be eligible.

Will I have to take any new medication?

No, this study does not involve any medication. It's about collecting information through questionnaires.

What is 'Quality of Life' data?

This refers to information about your overall well-being, including your physical health, emotional state, social life, and how you cope with daily activities.

What if my cancer comes back?

To be eligible, you must currently show no signs that your cancer has returned (you must be 'disease-free'). This study is focused on survivors without active disease.